A Study to Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting
Clinical trial NCT03720561 · COMPLETED
Trial details
- NCT number
- NCT03720561
- Sponsor
- Janssen-Cilag S.p.A.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-10-30
- Primary completion
- 2021-11-12
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.